STAAR Surgical (STAA) Reports In-Line Q3 EPS, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
STAAR Surgical Reports Third Quarter Results
October 30, 2019 4:03 PM EDTLAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the third quarter ended September 27, 2019.
Third Quarter 2019 Overview
Net Sales of $39.1 Million Up 23% from the Prior Year Quarter ICL Sales of $33.8 Million Up 28% from the Prior Year Quarter ICL Units Up 35% from the Prior Year Quarter Gross Margin at 74.4% vs. 75.1% in the Prior Year... More